BioCentury | Jan 31, 2008
Distillery Therapeutics

This Week in Therapeutics

...to treat obesity. The virtual screening method is not patented; available for nonexclusive licensing from MolSoft LLC...
...J. Monsma Jr., Schering-Plough Research Institute, Kenilworth, N.J. e-mail: frederick.monsma@spcorp.com Contact: Andrew J. W. Orry, MolSoft LLC...
BioCentury | May 26, 2003
Company News

Molsoft LLC other research news

...found to have diverse chemistries. Antagonists against the receptor may be useful for treating hyperthyroidism. Molsoft LLC...
BioCentury | Jul 29, 2002
Company News

Plexus, GlaxoSmithKline deal

...vaccines. Plexus will use its structure-based vaccine design methods and ICM molecular modeling technology from Molsoft LLC...
BioCentury | Sep 17, 2001
Company News

Molsoft LLC, Plexus deal

...to treat or prevent infectious diseases, drug-resistant microbes and chronic diseases associated with cryptic pathogens. Molsoft LLC...
BioCentury | Sep 17, 2001
Company News

Plexus board of directors update

...Plexus Vaccine Inc. , San Diego, Calif. Business: Infectious diseases Appointed: Ruben Abagyan, founder of Molsoft LLC WIR...
BioCentury | Jul 9, 2001
Strategy

Raise money, move downstream

...a separate deal to accelerate structure-guided drug discovery by incorporating Virtual Ligand Screening technology from MolSoft LLC...
BioCentury | Nov 6, 2000
Company News

MolSoft LLC, Syrrx deal

...small molecules. Syrrx will have exclusive rights to use VLS in combination with structural proteomics. MolSoft LLC...
Items per page:
1 - 7 of 7
BioCentury | Jan 31, 2008
Distillery Therapeutics

This Week in Therapeutics

...to treat obesity. The virtual screening method is not patented; available for nonexclusive licensing from MolSoft LLC...
...J. Monsma Jr., Schering-Plough Research Institute, Kenilworth, N.J. e-mail: frederick.monsma@spcorp.com Contact: Andrew J. W. Orry, MolSoft LLC...
BioCentury | May 26, 2003
Company News

Molsoft LLC other research news

...found to have diverse chemistries. Antagonists against the receptor may be useful for treating hyperthyroidism. Molsoft LLC...
BioCentury | Jul 29, 2002
Company News

Plexus, GlaxoSmithKline deal

...vaccines. Plexus will use its structure-based vaccine design methods and ICM molecular modeling technology from Molsoft LLC...
BioCentury | Sep 17, 2001
Company News

Molsoft LLC, Plexus deal

...to treat or prevent infectious diseases, drug-resistant microbes and chronic diseases associated with cryptic pathogens. Molsoft LLC...
BioCentury | Sep 17, 2001
Company News

Plexus board of directors update

...Plexus Vaccine Inc. , San Diego, Calif. Business: Infectious diseases Appointed: Ruben Abagyan, founder of Molsoft LLC WIR...
BioCentury | Jul 9, 2001
Strategy

Raise money, move downstream

...a separate deal to accelerate structure-guided drug discovery by incorporating Virtual Ligand Screening technology from MolSoft LLC...
BioCentury | Nov 6, 2000
Company News

MolSoft LLC, Syrrx deal

...small molecules. Syrrx will have exclusive rights to use VLS in combination with structural proteomics. MolSoft LLC...
Items per page:
1 - 7 of 7